1. Spinal anesthesia is produced by injecting local anesthetic into a specific anatomic compartment. Into which space is the local anesthetic deposited during spinal anesthesia?
A) The epidural space, the potential space outside the dura mater
B) The subdural space, between the dura mater and the arachnoid membrane
C) The subarachnoid space, where the drug mixes directly with cerebrospinal fluid (CSF)
D) The paravertebral space, alongside the vertebral column
E) The interpleural space, between the parietal and visceral pleura
ANSWER: C
Rationale:
Spinal (intrathecal) anesthesia places local anesthetic directly into the subarachnoid space, where it mixes with cerebrospinal fluid (CSF) and bathes the nerve roots of the cauda equina with no intervening tissue barrier. This direct CSF contact is why a small mass of drug (a few milligrams) produces dense surgical block within minutes, and it is the defining feature that distinguishes spinal from epidural anesthesia.
Option A: Option A describes epidural anesthesia, a different technique in which drug is deposited outside the dura and must diffuse across it; that is not spinal anesthesia.
Option B: Option B misidentifies the target as the subdural space, a thin potential plane that is not the intended compartment for either spinal or epidural blockade.
Option D: Option D describes a paravertebral block, a peripheral technique unrelated to neuraxial drug delivery.
Option E: Option E describes interpleural analgesia, a chest-wall technique that does not involve the neuraxis at all.
2. A resident contrasts epidural anesthesia with spinal anesthesia. Which statement correctly describes where the local anesthetic is placed during epidural anesthesia?
A) Into the epidural space, a potential space outside the dura mater containing fat, veins, and connective tissue, from which the drug must diffuse to reach the nerve roots
B) Into the cerebrospinal fluid (CSF) of the subarachnoid space, in direct contact with the spinal nerve roots
C) Directly into the substance of the spinal cord itself
D) Into the central canal of the spinal cord
E) Into the cisterna magna at the base of the skull
ANSWER: A
Rationale:
Epidural anesthesia deposits local anesthetic into the epidural space, the potential space lying outside the dura mater that contains epidural fat, a venous plexus, and areolar connective tissue. Because the drug is outside the dura, it must distribute through this tissue matrix and cross the dura to reach the nerve roots, which is why epidural anesthesia requires substantially larger doses and has a slower onset than spinal anesthesia.
Option B: Option B describes spinal (subarachnoid) anesthesia, in which the drug enters the CSF directly; that is the contrasting technique, not epidural.
Option C: Option C is incorrect because local anesthetic is never intentionally injected into the spinal cord substance, which would cause direct neural injury.
Option D: Option D misidentifies the central canal, a tiny structure within the cord that is not a target for any clinical block.
Option E: Option E describes a location used historically for cisternal puncture, not for epidural anesthesia.
3. The term "baricity" is central to understanding spinal anesthesia. What does the baricity of a spinal local anesthetic solution describe?
A) The total milligram dose of local anesthetic contained in the syringe
B) The speed at which the local anesthetic crosses the nerve membrane
C) The percentage concentration of the local anesthetic in the solution
D) The density of the injected solution relative to the density of cerebrospinal fluid (CSF)
E) The duration of motor block produced by the local anesthetic
ANSWER: D
Rationale:
Baricity is defined as the ratio of the density of the injected solution to the density of CSF at body temperature (37 degrees C). It is the property that determines how a spinal solution moves within the subarachnoid space under the influence of gravity: a solution denser than CSF (hyperbaric) sinks toward dependent regions, while one less dense (hypobaric) rises. Understanding baricity is what allows the clinician to direct the spread of block by positioning the patient.
Option A: Option A describes the dose (mass) of drug, which determines block level but is a separate quantity from baricity.
Option B: Option B describes onset kinetics governed by lipid solubility and pKa, not baricity.
Option C: Option C describes concentration, which influences block density but is not the same as the solution's density relative to CSF.
Option E: Option E describes duration, a pharmacodynamic property unrelated to the definition of baricity.
4. A hyperbaric bupivacaine solution (bupivacaine in 8% dextrose) is injected into the subarachnoid space of a patient lying supine. Based on its baricity, how will this solution behave within the CSF?
A) It will remain fixed at the exact level of injection regardless of patient position
B) It will be heavier than CSF and sink toward the most dependent (gravity-dependent) regions of the subarachnoid space
C) It will be lighter than CSF and rise toward the most superior regions of the subarachnoid space
D) It will distribute evenly throughout the entire CSF within seconds, producing a uniform block from sacrum to skull
E) It will be actively pumped cephalad by pulsatile CSF flow independent of gravity
ANSWER: B
Rationale:
A hyperbaric solution is, by definition, denser than CSF, so gravity causes it to sink toward the most dependent portion of the subarachnoid space. In a supine patient the dependent regions are determined by the natural spinal curvature, and the clinician can deliberately steer spread by tilting the patient (for example, head-down Trendelenburg to encourage cephalad spread, or sitting to concentrate drug sacrally). This predictable, position-dependent behavior is precisely why hyperbaric solutions are favored when controlled block level matters.
Option A: Option A is incorrect because position independence describes an isobaric solution, not a hyperbaric one.
Option C: Option C describes the behavior of a hypobaric solution, which is lighter than CSF and rises; it inverts the correct relationship.
Option D: Option D overstates the situation by claiming instantaneous uniform distribution, which does not occur and would eliminate the clinician's ability to control block level.
Option E: Option E fabricates an active pumping mechanism; spread of a hyperbaric solution is governed chiefly by gravity and position, not by an independent cephalad pump.
5. When predicting the level (height) a spinal block will reach, which property of the injected local anesthetic is the primary determinant?
A) The concentration (percentage) of the local anesthetic solution
B) The temperature of the solution at the moment of injection
C) The specific brand of local anesthetic chosen
D) The volume of solution injected, independent of how much drug it contains
E) The total mass of drug injected, measured in milligrams
ANSWER: E
Rationale:
The level a spinal block reaches is governed primarily by the total mass of drug injected (milligrams), together with baricity and patient position. Mass is the quantity the clinician thinks in: a given number of milligrams of hyperbaric bupivacaine will tend toward a characteristic block height, and dose adjustments are made in milligrams. Option D isolates volume from drug content, which is misleading: it is the mass of drug (a product of concentration and volume) that drives level, not volume considered on its own.
Option A: Option A is incorrect because concentration influences block density (how profound the motor and sensory block is) rather than how high the block rises.
Option B: Option B is incorrect; while warming a solution slightly alters density, temperature is not a primary determinant of block level in clinical practice.
Option C: Option C is incorrect because block level is determined by mass and baricity, not by the manufacturer of an equivalent agent.
6. Which local anesthetic agent is the most widely used standard choice for producing dense, reliable surgical spinal anesthesia of 90 to 150 minutes' duration for lower abdominal, pelvic, and lower extremity procedures?
A) Hyperbaric bupivacaine 0.5%
B) Preservative-free chloroprocaine 1%
C) Cocaine 4% topical solution
D) Plain (unbuffered) ropivacaine 0.2%
E) Benzocaine 20% gel
ANSWER: A
Rationale:
Hyperbaric bupivacaine 0.5% is the dominant agent for spinal surgical anesthesia worldwide because it provides dense, reliable, and predictable block lasting roughly 90 to 150 minutes at typical doses of 10 to 15 mg, which suits the duration of most lower abdominal, pelvic, and lower extremity operations. Its long duration and dependable spread are the reasons it became the default surgical spinal agent.
Option B: Option B, chloroprocaine, is an excellent agent for brief ambulatory spinals but its very short duration makes it unsuitable as the general standard for longer surgical cases.
Option C: Option C, cocaine, is a topical agent of historical interest and is never used for spinal anesthesia.
Option D: Option D, low-concentration ropivacaine, is used for dilute epidural infusions for analgesia, not as the standard dense surgical spinal agent.
Option E: Option E, benzocaine, is a topical-only agent used on mucous membranes and has no role in neuraxial anesthesia.
7. Shortly after a spinal anesthetic is established, many patients develop a drop in blood pressure. What is the principal mechanism responsible for this hypotension?
A) A direct toxic effect of the local anesthetic on cardiac muscle causing pump failure
B) An allergic (anaphylactic) reaction to the local anesthetic agent
C) Blockade of sympathetic nerve fibers, producing vasodilation and reduced venous return
D) Local anesthetic-induced constriction of the coronary arteries
E) A rise in systemic vascular resistance from unopposed sympathetic outflow
ANSWER: C
Rationale:
Neuraxial local anesthetic blocks the preganglionic sympathetic fibers that exit the spinal cord, producing vasodilation of both resistance and capacitance vessels. The resulting decrease in venous return (preload) and systemic vascular resistance lowers blood pressure; this sympathectomy-mediated hypotension is the expected and most common hemodynamic consequence of spinal anesthesia.
Option A: Option A is incorrect because routine clinical spinal doses do not produce direct cardiac toxicity; that concern belongs to systemic local anesthetic toxicity from inadvertent intravascular injection, a different scenario.
Option B: Option B is incorrect because true allergy to amide local anesthetics is rare and is not the routine cause of post-spinal hypotension.
Option D: Option D fabricates coronary constriction as a mechanism, which is not how neuraxial blockade lowers pressure.
Option E: Option E inverts the physiology: the sympathetic block lowers vascular resistance rather than raising it.
8. A patient develops a post-dural puncture headache (PDPH) several days after a neuraxial procedure. Which feature is most characteristic of this headache and helps distinguish it from other causes?
A) It is most severe immediately on waking and improves steadily through the day regardless of position
B) It is constant in intensity and completely unaffected by whether the patient is lying down or standing up
C) It is accompanied by a fever and neck rigidity that point to meningitis as the cause
D) It is postural: mild or absent when the patient is lying flat and severe when the patient sits or stands upright
E) It is a sharp, electric, one-sided facial pain triggered by chewing or touching the face
ANSWER: D
Rationale:
The hallmark of PDPH is its postural (positional) character: the headache is mild or absent when the patient is supine and becomes severe when the patient sits or stands. This occurs because loss of CSF through the dural puncture lowers CSF pressure, allowing downward traction on pain-sensitive structures when the patient is upright; lying flat relieves that traction. The positional pattern is the single most useful bedside feature for recognizing PDPH. Option A misdescribes the temporal pattern and omits the defining postural relationship.
Option B: Option B is incorrect precisely because a position-independent headache argues against PDPH.
Option C: Option C describes the warning features of meningitis, an important alternative diagnosis but not the characteristic PDPH pattern.
Option E: Option E describes trigeminal neuralgia, an unrelated facial pain syndrome.
9. Compared with spinal anesthesia, epidural anesthesia generally requires a much larger dose of local anesthetic to achieve a similar block level. Which statement best explains this difference?
A) The epidural drug is destroyed by enzymes in the epidural space, so extra drug must be given to compensate
B) The epidural space is a larger compartment and the drug must distribute through tissue and cross the dura to reach the nerve roots, so a higher dose is needed
C) Epidural local anesthetics are inherently far less potent molecules than spinal local anesthetics
D) The epidural route eliminates the drug through the kidneys before it can act, requiring a larger starting dose
E) Spinal anesthesia uses larger doses than epidural anesthesia, so the premise is reversed
ANSWER: B
Rationale:
The epidural space is a larger, tissue-filled compartment than the subarachnoid space, and drug placed there must distribute through fat and connective tissue and diffuse across the dura before reaching the nerve roots. Because of this larger volume of distribution and the diffusion barrier, epidural anesthesia typically requires roughly 5 to 10 times the dose used for an equivalent spinal block. Option D invokes renal elimination, which is irrelevant to the immediate local dosing difference between the two neuraxial routes.
Option A: Option A fabricates local enzymatic destruction as the explanation, which is not the mechanism.
Option C: Option C is incorrect because the same agents (for example, bupivacaine) are used by both routes; the difference is anatomic, not a difference in molecular potency.
Option E: Option E reverses the well-established relationship; spinal anesthesia uses far smaller doses than epidural anesthesia.
10. In epidural anesthesia, the clinician can adjust both the volume and the concentration of the local anesthetic solution. Which pairing correctly matches each property to what it primarily controls?
A) Volume primarily controls how many spinal segments are covered (spread), while concentration primarily controls how dense the block is (sensory versus motor)
B) Volume primarily controls block density, while concentration primarily controls the number of segments covered
C) Both volume and concentration control only the duration of the block and have no effect on spread or density
D) Concentration controls how quickly the drug is eliminated, while volume controls allergic potential
E) Neither volume nor concentration influences the block; only the brand of drug matters
ANSWER: A
Rationale:
In the epidural space, volume and concentration do different jobs. The volume of solution injected primarily determines how widely the drug spreads, and therefore how many spinal segments (dermatomes) are covered. Concentration primarily determines the density of the block: a low concentration produces sensory analgesia while sparing motor function, whereas a high concentration produces dense sensorimotor block. This is the pharmacologic basis for tailoring epidural solutions, most visibly in obstetrics where a dilute solution relieves pain while preserving the strength needed to push. Option E denies any effect of volume or concentration, which contradicts the foundation of epidural dosing.
Option B: Option B reverses the two relationships.
Option C: Option C incorrectly restricts both properties to duration alone, ignoring their well-defined roles in spread and density.
Option D: Option D fabricates roles in elimination and allergy that neither property serves in this context.
11. A standard epidural test dose contains 3 mL of lidocaine 1.5% with epinephrine 1:200,000 (about 15 micrograms of epinephrine). In an awake patient, what does a sudden rise in heart rate of 20 beats per minute or more within about a minute of injection most likely indicate?
A) The catheter tip is correctly positioned in the epidural space and the test is reassuring
B) The patient is having an allergic reaction to lidocaine
C) The catheter has been placed intravascularly, and the epinephrine has entered the bloodstream
D) The catheter is in the subarachnoid space and is producing a spinal block
E) The epidural space is too large to hold the injected volume
ANSWER: C
Rationale:
The epinephrine in the test dose is a deliberate marker for intravascular placement. If the catheter lies in a blood vessel, the roughly 15 micrograms of epinephrine reaches the circulation and produces a brisk, transient rise in heart rate (commonly 20 beats per minute or more) within about a minute. This rapid, quantifiable response is the most reliable sign of intravascular catheter placement in an awake patient and warns the clinician not to inject the full therapeutic dose.
Option A: Option A is incorrect because a marked tachycardic response is precisely what a correctly placed (epidural) catheter does NOT produce.
Option B: Option B is incorrect; an allergic reaction does not produce this characteristic epinephrine-driven heart rate signature.
Option D: Option D describes the OTHER limb of the test dose: the lidocaine component detects subarachnoid placement by producing motor block, not by raising heart rate.
Option E: Option E fabricates a relationship between epidural space size and tachycardia.
12. The same epidural test dose also delivers about 45 mg of lidocaine. If the catheter is misplaced in the subarachnoid space, what response would this lidocaine component be expected to produce, warning the clinician before the full dose is given?
A) A gradual numbness of the lips and a metallic taste over the next 30 minutes
B) A slow rise in blood pressure over several minutes
C) No detectable change, because 45 mg of lidocaine is too small a dose to have any effect anywhere
D) A localized skin rash at the injection site
E) A rapidly developing dense motor block of the lower extremities within a few minutes
ANSWER: E
Rationale:
When the catheter is mistakenly in the subarachnoid space, 45 mg of lidocaine delivered intrathecally is a substantial spinal dose and produces a rapidly ascending, dense motor block of the lower extremities within two to three minutes. This early, unmistakable motor block is the warning sign that the catheter is intrathecal, allowing the clinician to abort before injecting the much larger therapeutic epidural dose, which intrathecally could cause a total spinal.
Option A: Option A describes early systemic local anesthetic toxicity from intravascular absorption, a different problem with a slower and different presentation.
Option B: Option B describes neither limb of the test dose correctly; a slow pressure rise is not the intrathecal marker.
Option C: Option C is incorrect because, although 45 mg is modest for the epidural space, it is a meaningful spinal dose when delivered into CSF.
Option D: Option D fabricates a dermatologic response unrelated to the test dose's purpose.
13. Intrathecal opioids behave differently depending on their lipid solubility. Which statement correctly contrasts intrathecal fentanyl (highly lipid-soluble) with intrathecal morphine (poorly lipid-soluble)?
A) Both fentanyl and morphine remain in the CSF for many hours and carry an identical risk of delayed respiratory depression
B) Fentanyl is taken up rapidly into the spinal cord, giving fast segmental analgesia, whereas morphine lingers in the CSF and spreads upward over hours, providing long analgesia but with a risk of delayed respiratory depression
C) Morphine acts within seconds and clears within minutes, while fentanyl provides 24 hours of analgesia
D) Neither agent provides any analgesia when given intrathecally because opioids work only when given intravenously
E) Fentanyl spreads rostrally over many hours and morphine produces only brief segmental analgesia
ANSWER: B
Rationale:
Lipid solubility governs how an intrathecal opioid behaves. Highly lipid-soluble fentanyl is rapidly taken up into the spinal cord near the level of injection, producing fast, segmental analgesia with limited upward (rostral) spread. Poorly lipid-soluble morphine stays in the CSF much longer and is carried rostrally over hours, which gives prolonged analgesia but also creates the well-known risk of delayed respiratory depression up to 18 to 24 hours later, mandating extended monitoring.
Option A: Option A is incorrect because the two drugs differ markedly in CSF residence and respiratory risk.
Option C: Option C reverses the kinetics of the two drugs.
Option D: Option D is incorrect because intrathecal opioids are effective analgesics acting at spinal cord opioid receptors.
Option E: Option E inverts the behavior of each agent, attributing morphine's rostral spread to fentanyl and vice versa.
14. A patient has a disabling post-dural puncture headache (PDPH) that has not responded to bed rest, hydration, and caffeine. What is the definitive treatment that directly addresses the underlying cause?
A) A higher dose of oral caffeine continued for two more weeks
B) Strict flat bed rest for a full week with no other intervention
C) Lumbar puncture to drain additional CSF and relieve pressure
D) An epidural blood patch, in which autologous blood is injected into the epidural space to seal the dural leak
E) Broad-spectrum intravenous antibiotics to treat presumed infection
ANSWER: D
Rationale:
The epidural blood patch is the definitive treatment for disabling PDPH because it directly addresses the cause: a small volume of the patient's own (autologous) blood is injected into the epidural space at or near the puncture level, where it clots and seals the dural hole, restoring normal CSF pressure and typically relieving the headache within minutes. Conservative measures provide only temporary symptomatic relief and do not close the leak. Option A is incomplete because caffeine and other conservative measures do not address the underlying dural defect and are often inadequate for disabling headache. Option C is the opposite of what is needed; removing more CSF would worsen the low-pressure state driving the headache.
Option B: Option B is incorrect because bed rest alone, while sometimes used short term, does not seal the leak and is not definitive.
Option E: Option E is incorrect because PDPH is not an infectious process, so antibiotics do not treat it.
15. A woman at term is positioned for a neuraxial procedure. To prevent the gravid uterus from compressing the major abdominal vessels and causing maternal hypotension, which measure is mandatory?
A) Left uterine displacement, achieved by tilting the patient about 15 degrees to the left or placing a wedge under the right hip
B) Placing the patient flat on her back (fully supine) for the entire procedure
C) Steep head-down (Trendelenburg) positioning maintained throughout delivery
D) Having the patient stand upright during the block
E) Firm continuous downward pressure on the upper abdomen
ANSWER: A
Rationale:
At term the gravid uterus can compress the inferior vena cava and aorta when the woman lies supine, sharply reducing venous return and uteroplacental perfusion (aortocaval compression). Left uterine displacement, produced by a leftward tilt of roughly 15 degrees or a wedge under the right hip, shifts the uterus off the great vessels and is mandatory during any neuraxial procedure in a term parturient.
Option B: Option B is the very position that causes aortocaval compression and is therefore exactly what must be avoided.
Option C: Option C, steep Trendelenburg, does not relieve lateral vessel compression and can adversely affect block spread and respiration.
Option D: Option D is impractical and unsafe during neuraxial blockade and does not reliably relieve compression.
Option E: Option E would increase, not relieve, pressure on the great vessels.
16. During spinal anesthesia for an elective cesarean delivery, the mother becomes hypotensive. Which vasopressor is currently the preferred agent for preventing and treating this hypotension, based on its favorable effect on uteroplacental blood flow?
A) Dopamine infusion titrated to renal perfusion
B) Isoproterenol given for its beta-adrenergic effect
C) Phenylephrine, an alpha-adrenergic agonist
D) Nitroglycerin to improve placental perfusion
E) Furosemide to reduce intravascular volume
ANSWER: C
Rationale:
Phenylephrine, a selective alpha-adrenergic agonist, has become the preferred vasopressor for spinal anesthesia-induced hypotension during cesarean delivery. Randomized evidence shows it maintains maternal blood pressure and uteroplacental perfusion well, with better fetal acid-base status than ephedrine, despite producing a modestly lower maternal heart rate. It is typically given as a titrated infusion to keep systolic pressure near baseline.
Option A: Option A, dopamine, is not the obstetric agent of choice for this indication and offers no uteroplacental advantage here.
Option B: Option B, isoproterenol, is a beta-agonist that lowers systemic vascular resistance and would worsen the vasodilatory hypotension.
Option D: Option D, nitroglycerin, is a vasodilator that would further drop blood pressure rather than support it.
Option E: Option E, furosemide, is a diuretic that would reduce preload and aggravate the hypotension.
17. Applying what you have learned about baricity and position: a small dose of hyperbaric local anesthetic is given to a patient who then remains seated for several minutes. For which type of procedure is this approach especially well suited, and why?
A) An upper abdominal procedure, because the hyperbaric drug rises to high thoracic levels when the patient sits
B) A perineal or anorectal procedure (a saddle block), because the hyperbaric drug sinks to and concentrates in the lowest lumbosacral segments while the patient sits
C) A shoulder procedure, because seated positioning directs the block to the cervical roots
D) A procedure requiring a block up to the nipple line (T4), because sitting drives the drug to mid-thoracic levels
E) Any procedure, because position has no influence on where a hyperbaric drug settles
ANSWER: B
Rationale:
This question applies two earlier concepts together: a hyperbaric solution sinks to the most dependent region, and patient position directs where that region is. In a seated patient the lowest (most dependent) part of the subarachnoid space is the sacral and lower lumbar region, so a small hyperbaric dose concentrates there, producing a saddle block ideal for perineal and anorectal surgery with minimal lower-extremity motor block. Option E contradicts the established principle that position strongly influences the spread of a hyperbaric solution.
Option A: Option A is incorrect because in the sitting position the hyperbaric drug sinks caudally rather than rising to the upper abdomen.
Option C: Option C is incorrect because seated positioning directs hyperbaric drug toward the sacrum, not up to the cervical roots.
Option D: Option D is incorrect because sitting concentrates the drug low rather than driving it up to T4.
18. You learned that block level depends on the mass of drug given, but that patient factors can change how far a given dose spreads. A woman at term needs a spinal anesthetic for cesarean delivery. Compared with a non-pregnant adult of the same height, how should her intrathecal dose generally be adjusted to reach the same block level, and why?
A) She needs a larger dose, because pregnancy increases CSF volume and dilutes the drug
B) She needs the identical dose, because pregnancy has no effect on the subarachnoid space
C) She needs a larger dose, because the fetus absorbs much of the intrathecal drug
D) She needs a smaller dose, because engorged epidural veins reduce CSF volume, so the same dose would spread to a higher level
E) Dose is irrelevant in pregnancy because block level is set entirely by the type of drug, not its amount
ANSWER: D
Rationale:
This applies the mass-determines-level concept together with the patient factors that modify spread. At term, engorged epidural veins (from aortocaval compression) compress the subarachnoid space and reduce CSF volume, so a given mass of drug spreads to a higher level than it would in a non-pregnant patient. Accordingly, the parturient generally requires a smaller intrathecal dose to reach the same target level. Option C invokes fetal absorption of intrathecal drug, which is not the mechanism governing maternal block level. Option E contradicts the foundational principle that the mass of drug is a primary determinant of block level.
Option A: Option A reverses the physiology by claiming increased CSF volume.
Option B: Option B ignores the well-described reduction in CSF volume at term.
19. You know that neuraxial block interrupts sympathetic fibers. If a spinal block rises unexpectedly high and reaches the T1 to T4 levels, the sympathetic fibers that accelerate the heart (the cardiac accelerator fibers) are blocked. What heart rate change would you predict, and why?
A) Bradycardia, because blockade of the T1 to T4 cardiac accelerator fibers removes sympathetic drive to the heart, leaving parasympathetic (vagal) tone relatively unopposed
B) Tachycardia, because blocking the cardiac accelerator fibers directly speeds the sinoatrial node
C) No heart rate change, because the cardiac accelerator fibers have no influence on heart rate
D) An immediate, sustained rise in blood pressure from the high block
E) Bradycardia, but only because the local anesthetic chemically stimulates the vagus nerve
ANSWER: A
Rationale:
This applies the sympathectomy concept to a specific block level. The sympathetic fibers that increase heart rate (cardiac accelerators) leave the cord at roughly T1 to T4. A high spinal block reaching these levels removes that sympathetic drive, so parasympathetic (vagal) influence is left relatively unopposed and the heart rate falls, producing bradycardia. Recognizing this is why a high block is treated in part with agents such as atropine and ephedrine. Option E reaches the correct endpoint (bradycardia) by a fabricated mechanism; the local anesthetic does not chemically stimulate the vagus, it removes opposing sympathetic tone.
Option B: Option B reverses the expected direction; blocking accelerator fibers slows rather than speeds the heart.
Option C: Option C is incorrect because the cardiac accelerator fibers clearly do influence heart rate.
Option D: Option D is incorrect because a high sympathetic block lowers blood pressure through vasodilation rather than raising it.
20. A patient with an epidural catheter in place for postoperative analgesia develops new, progressively worsening lower-extremity weakness along with back pain. The infusion is stopped, but the weakness continues to advance. Which complication must be suspected immediately, and how should it be regarded?
A) Ordinary pharmacologic over-blockade that will simply resolve on its own with no further action
B) A post-dural puncture headache, which explains the back discomfort
C) A mild allergic reaction to the infusion that can be observed overnight
D) Expected motor block from the local anesthetic that requires no evaluation
E) An epidural hematoma compressing the spinal cord, which is a neurosurgical emergency requiring urgent imaging and decompression
ANSWER: E
Rationale:
This applies the earlier teaching that motor weakness which persists or progresses after the infusion is reduced or stopped is NOT simple pharmacologic block. New, progressive lower-extremity weakness with back pain in a patient with a neuraxial catheter must be treated as a possible epidural hematoma compressing the cord, a neurosurgical emergency. Urgent MRI and prompt surgical decompression are needed, because delay beyond a short window risks permanent neurologic injury. Option A is dangerous because progressive weakness that does not improve after stopping the infusion is precisely what argues against benign over-blockade. Option D normalizes a red-flag finding; progressive deficit after stopping the infusion always requires urgent evaluation.
Option B: Option B is incorrect; PDPH is a postural headache, not progressive leg weakness.
Option C: Option C is incorrect because this presentation is not an allergic reaction and cannot be safely observed without imaging.
21. Recall that concentration controls block density. A laboring patient needs effective pain relief from her epidural while keeping enough leg strength to move and to push during delivery. Applying the concentration-density principle, what should the clinician choose?
A) A high concentration of local anesthetic, to guarantee a dense block including full motor blockade
B) The highest available concentration combined with the largest possible volume
C) A low (dilute) concentration of local anesthetic, often combined with a small dose of opioid, to relieve pain while sparing motor function
D) A concentration so low that it produces no sensory effect at all
E) Concentration is irrelevant here; only the brand of local anesthetic determines whether motor function is preserved
ANSWER: C
Rationale:
This applies the concentration-density rule to obstetric analgesia. Because concentration governs block density, a low (dilute) concentration of local anesthetic produces sensory analgesia while largely sparing motor fibers, which is exactly what labor analgesia requires; adding a small dose of opioid improves pain relief without increasing motor block. This dilute local anesthetic-plus-opioid strategy lets the patient remain comfortable yet able to move and push. Option B compounds the problem by maximizing both density and spread, the opposite of the goal. Option D goes too far, implying a concentration that abolishes the analgesia that is the whole point of the epidural. Option E denies the central role of concentration in determining block density.
Option A: Option A is incorrect because a high concentration produces dense motor block and would impair the patient's ability to push and ambulate.
22. Applying what you learned about matching the agent to the clinical goal: a healthy outpatient is scheduled for a short (about 45-minute) procedure under spinal anesthesia and needs to recover block function quickly so she can be discharged the same day. Which spinal agent best fits this goal?
A) Hyperbaric bupivacaine 0.5%, chosen for its long 90 to 150 minute duration
B) Preservative-free chloroprocaine, chosen for its rapid onset, short duration, and quick complete recovery with minimal risk of transient neurologic symptoms
C) Intrathecal morphine alone, chosen to provide the surgical block for the case
D) Tetracaine with epinephrine, chosen specifically to prolong the block for many hours
E) Any long-acting agent, because duration does not affect readiness for same-day discharge
ANSWER: B
Rationale:
This applies the agent-selection principle to an ambulatory setting. Preservative-free chloroprocaine has a rapid onset, a short and predictable duration (roughly 60 to 90 minutes), full recovery suited to same-day discharge, and a very low risk of transient neurologic symptoms, making it the preferred choice for brief ambulatory spinals. Option A is a long-acting agent whose 90 to 150 minute duration would unnecessarily delay recovery and discharge for a short case. Option D deliberately prolongs the block, the opposite of the stated goal.
Option C: Option C is incorrect because intrathecal morphine is an analgesic adjunct, not a surgical anesthetic, and would not by itself provide the operative block; it also carries delayed respiratory depression risk unsuited to rapid discharge.
Option E: Option E ignores the principle that block duration directly affects how soon an ambulatory patient can safely be discharged.
This Web-based pharmacology and disease-based integrated teaching site is based on reference materials that are believed reliable and consistent with standards accepted at the time of development.
Possibility of error and on-going research and development in medical sciences do not allow assurance that the information contained herein is in every respect accurate or complete.
Users should confirm the information contained herein with other sources.
This site should only be considered as a teaching aid for undergraduate and graduate biomedical education and is intended only as a teaching site.
Information contained here should not be used for patient management and should not be used as a substitute for consultation with practicing medical professionals.
Users of this website should check the product information sheet included in the package of any drug they plan to administer to be certain that the information contained in this site is accurate and that changes have not been made in the recommended dose or in the contraindications for administration.
Medical or other information thus obtained should not be used as a substitute for consultation with practicing medical or scientific or other professionals.